BeiGene, Ltd.: BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, yesterday announced the opening of a new